Quantcast
Last updated on April 18, 2014 at 13:02 EDT

Latest Unsolved problems in neuroscience Stories

Sleep Problems Could Affect Your Memory
2012-02-15 04:59:40

The amount and quality of sleep you get at night may affect your memory later in life, according to research that was released this week and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012. "Disrupted sleep appears to be associated with the build-up of amyloid plaques, a hallmark marker of Alzheimer's disease, in the brains of people without memory problems," said study author Yo-El Ju, MD, with Washington University...

2012-02-14 15:48:00

NEW ORLEANS, Feb. 14, 2012 /PRNewswire-USNewswire/ -- The amount and quality of sleep you get at night may affect your memory later in life, according to research that was released today and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012. "Disrupted sleep appears to be associated with the build-up of amyloid plaques, a hallmark marker of Alzheimer's disease, in the brains of people without memory problems,"...

2012-02-14 10:27:28

New potential therapy that restores motor function being planned for clinical trial Medical researchers at the University of Alberta have discovered a promising new therapy for Huntington disease that restores lost motor skills and may delay or stop the progression of the disease based on lab model tests, says the lead researcher. Because the new therapy uses a molecule already being used in clinical trials for other diseases, it could be used in a clinical trial for Huntington disease...

2012-02-14 07:30:00

CAMBRIDGE, Mass., Feb. 14, 2012 /PRNewswire-USNewswire/ -- The ALS Therapy Development Institute (ALS TDI) will launch a Phase II clinical trial on TDI 132 (aka: fingolimod/Gilenya®) as a potential treatment for ALS (Lou Gehrig's disease). Fingolimod is currently being marketed by Novartis AG as Gilenya® as a treatment for some forms of multiple sclerosis. (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO) "Getting to this point was only possible because ALS...

Overeating Can Contribute To Memory Loss
2012-02-13 08:51:18

New research suggests that overeating may double the risk of memory loss, or mild cognitive impairment (MCI), in people age 70 and older. US scientists have shown that a high caloric intake can substantially increase the risk of developing MCI, which is the stage between normal memory loss that comes with aging and early Alzheimer´s disease. The findings were released today at aan.com and will be presented at the American Academy of Neurology´s 64th Annual Meeting in New...

Alzheimer’s Breakthrough: Drug Appeared To Reverse Symptoms In Mouse Trial
2012-02-10 10:23:41

Scientists, long searching for a cure for Alzheimer´s, a reporting a dramatic breakthrough: a drug that quickly reverses the pathological, cognitive and memory deficits in mice afflicted with the disease. The results point to the significant potential that the drug, bexarotene, could help the more than 5 million Americans suffering from the brain disease. However, they cautioned that the study was only used in mice, and that the research needs much more work to determine if the...

2012-02-07 07:30:00

NEW YORK, Feb. 7, 2012 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases today announced it has filed two United States and one international patent application regarding passive and active immunotherapy approaches targeting abnormal forms of tau protein that lead to death of nerve cells in Alzheimer's disease....

2012-02-03 09:18:50

Researchers tease out toxic role of tau oligomers One of the most distinctive signs of the development of Alzheimer's disease is a change in the behavior of a protein that neuroscientists call tau. In normal brains, tau is present in individual units essential to neuron health. In the cells of Alzheimer's brains, by contrast, tau proteins aggregate into twisted structures known as "neurofibrillary tangles." These tangles are considered a hallmark of the disease, but their precise role in...

2012-02-02 12:44:00

NEW YORK, Feb. 2, 2012 /PRNewswire/ -- Intellect Neurosciences, Inc. (OTCBB:ILNS), a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment of Alzheimer's and other neurological diseases today issued the following Letter to Shareholders from Dr. Daniel Chain, Chairman and CEO. (Logo: http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) Dear Shareholder, 2011 was an exceptionally fruitful year for...

2012-02-02 09:16:42

Findings open new opportunities for studying Alzheimer´s and testing potential therapies For decades, researchers have debated whether Alzheimer's disease starts independently in vulnerable brain regions at different times, or if it begins in one region and then spreads to neuroanatomically connected areas. A new study by Columbia University Medical Center (CUMC) researchers strongly supports the latter, demonstrating that abnormal tau protein, a key feature of the neurofibrillary...